An esterase-activatable nanoprodrug mitigates severe spinal cord injury via alleviating ferroptosis and reprogramming inflammatory microenvironment

No abstract is available for this paper.

• Publication year

  2024

• Venue

  Nano Today

• Publication date

  2024-06-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/j.nantod.2024.102229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A natural biogenic nanozyme for scavenging superoxide radicals

  2024cited by this paper
• Recovery of walking after paralysis by regenerating characterized neurons to their natural target region

  2023cited by this paper
• Chiral metal-organic frameworks incorporating nanozymes as neuroinflammation inhibitors for managing Parkinson’s disease

  2023cited by this paper
• Carrier-Free Nanodrug Based on Co-Assembly of Methylprednisolone Dimer and Rutin for Combined Treatment of Spinal Cord Injury.

  2023cited by this paper
• DLP printed hDPSC-loaded GelMA microsphere regenerates dental pulp and repairs spinal cord.

  2023cited by this paper
• Reversing lung cancer radioresistance by hyperpermeable tellurium nanotherapeutics via remodeling tumor microenvironment

  2023cited by this paper
• Preventing acute lung injury from progressing to pulmonary fibrosis by maintaining ERS homeostasis through a multistage targeting nanomicelle

  2023cited by this paper
• Role of Trichocytic Keratins in Anti‐Neuroinflammatory Effects After Spinal Cord Injury

  2023cited by this paper
• Trehalose inhibits ferroptosis via NRF2/HO-1 pathway and promotes functional recovery in mice with spinal cord injury

  2022cited by this paper
• Hyaluronic acid extracellularly inhibits ferroptosis via cell-surface receptors in acute traumatic brain injury

  2022cited by this paper
• Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications.

  2022cited by this paper
• Traditional Chinese medicine active ingredients-based selenium nanoparticles regulate antioxidant selenoproteins for spinal cord injury treatment

  2022cited by this paper
• Nanorepairers Rescue Inflammation‐Induced Mitochondrial Dysfunction in Mesenchymal Stem Cells

  2021cited by this paper
• An injury-induced serotonergic neuron subpopulation contributes to axon regrowth and function restoration after spinal cord injury in zebrafish

  2021cited by this paper
• Rational Design of Thermosensitive Hydrogel to Deliver Nanocrystals with Intranasal Administration for Brain Targeting in Parkinson's Disease

  2021cited by this paper
• Iron overload in the motor cortex induces neuronal ferroptosis following spinal cord injury

  2021cited by this paper
• Faculty Opinions recommendation of Microglia-organized scar-free spinal cord repair in neonatal mice.

  2020cited by this paper
• Scar Tissue-Targeting Polymer Micelle for Spinal Cord Injury Treatment.

  2020cited by this paper
• Vacancies on 2D transition metal dichalcogenides elicit ferroptotic cell death

  2020cited by this paper
• Parthenolide promotes the repair of spinal cord injury by modulating M1/M2 polarization via the NF-κB and STAT 1/3 signaling pathway

  2020cited by this paper
• The translational landscape in spinal cord injury: focus on neuroplasticity and regeneration

  2019cited by this paper
• Intravascular innate immune cells reprogrammed via intravenous nanoparticles to promote functional recovery after spinal cord injury

  2019cited by this paper
• The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

  2019cited by this paper
• Enhancement of the gut barrier integrity by a microbial metabolite through the Nrf2 pathway

  2019cited by this paper
• Reactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations.

  2018cited by this paper
• Urolithin A attenuates pro‐inflammatory mediator production by suppressing PI3‐K/Akt/NF‐&kgr;B and JNK/AP‐1 signaling pathways in lipopolysaccharide‐stimulated RAW264 macrophages: Possible involvement of NADPH oxidase‐derived reactive oxygen species

  2018cited by this paper
• Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents

  2016cited by this paper
• Esterase‐Activated Charge‐Reversal Polymer for Fibroblast‐Exempt Cancer Gene Therapy

  2016cited by this paper
• Urolithins, gut microbiota-derived metabolites of ellagitannins, inhibit LPS-induced inflammation in RAW 264.7 murine macrophages.

  2015cited by this paper
• The use of the antimicrobial peptide piscidin (PCD)-1 as a novel anti-nociceptive agent.

  2015cited by this paper
• Lipid Bilayer-Coated Curcumin-based Mesoporous Organosilica Nanoparticles for Cellular Delivery

  2015cited by this paper
• Regulation of ferroptotic cancer cell death by GPX4.

  2014cited by this paper

• Dynamic ROS-responsive injectable hydrogel incorporating nanozymes for spinal cord repair by alleviating oxidative stress and neuronal ferroptosis.

  2026cites this paper
• Photo-responsive polyprodrug supramolecular assemblies with self-accelerated subcellular delivery for synergistic photochemotherapy.

  2026cites this paper
• Immuno‐Neuroprotectants Facilitate Neurological Recovery via Sequestration of Neutrophil Extracellular Traps (NETs) and Promotion of Neuroregeneration

  2026cites this paper
• Orally Administered ZnxCeyO2/Se Hydrogel with Effective Antioxidant Activity for Treating Inflammatory Bowel Disease by Inhibiting Ferroptosis

  2025cites this paper
• Recent advances in nanotechnology for repairing spinal cord injuries.

  2025cites this paper
• Self-Assembling and Self-Immolative Three-in-One Prodrug Nanoassemblies for Self-Synergistic Combinational Anticancer Therapy.

  2025cites this paper
• Urolithin A in Central Nervous System Disorders: Therapeutic Applications and Challenges

  2025cites this paper
• A proactive cholinergic-like acidic fibroblast growth factor delivery system for efficient protein enrichment and native drug release in the central nervous system to promote repair of injured spinal cord.

  2025cites this paper
• Therapeutic Materials for Ferroptosis Inhibition: from Design to Applications

  2025cites this paper
• Micellar co-delivery of ibuprofen and zonisamide selectively to inflamed tissue following spinal cord injury

  2025cites this paper
• Dual-network hyaluronic acid hydrogel incorporating FGF21 and layered black phosphorus nanosheets for anti-ferroptosis therapy in spinal cord injury.

  2025cites this paper
• Stimuli-Responsive Nano Drug Delivery Systems for the Treatment of Neurological Diseases.

  2025cites this paper
• Self‐Enhancing Drug Pair‐Driven Selenium Nanotherapeutics Reverses Microglial Pyroptosis Through NLRP3/Caspase‐1 Pathway and Neuronal Apoptosis for Treatment of Spinal Cord Injury

  2025cites this paper
• ROS responsive quercetin nanoparticles with neuron-targeted peptide inhibits ferroptosis to repair spinal cord injury

  2024cites this paper